Treatment with gefitinib after erlotinib-induced liver injury: a case report

INTRODUCTION: Gefitinib and erlotinib have minor differences in their chemical structures, and thus it remains unclear whether the hepatotoxicity induced by one compound is affected by the other. The case of a patient who developed erlotinib-induced liver injury and was then treated with gefitinib w...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakatomi, Katsumi, Nakamura, Yoichi, Tetsuya, Iida, Kohno, Shigeru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3339363/
https://www.ncbi.nlm.nih.gov/pubmed/22188652
http://dx.doi.org/10.1186/1752-1947-5-593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3339363/
https://www.ncbi.nlm.nih.gov/pubmed/22188652
http://dx.doi.org/10.1186/1752-1947-5-593

Ejemplares similares